Deatra Josiah
Primary Care · Galveston, TXNPI 1568032340
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 44 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 9.3% — the pattern of someone who eats at a lot of different presentations. Among primary care clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 44 payments — averaging $99.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$408
- Regeneron Healthcare Solutions, Inc.$349
- Sanofi$321
- AbbVie$216
- Merck$206
- E.r. Squibb & Sons, L.L.C.$175
- plus $3K from 28 others
What the payments were for
- Food & beverage$4,378100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 4 | $408 |
| Regeneron Healthcare Solutions, Inc. | 3 | $349 |
| Sanofi | 3 | $321 |
| AbbVie | 2 | $216 |
| Merck | 2 | $206 |
| E.r. Squibb & Sons, L.L.C. | 2 | $175 |
| CSL Behring | 1 | $125 |
| Bristol Myers Squibb | 1 | $123 |
| GSK | 1 | $122 |
| AVEO Pharmaceuticals, Inc. | 1 | $122 |
| Johnson & Johnson | 1 | $122 |
| Pharmacosmos Therapeutics Inc. | 1 | $122 |
| Amgen | 1 | $122 |
| Beigene USA, Inc. | 1 | $121 |
| Pfizer | 1 | $119 |
| Viiv Healthcare Company | 1 | $119 |
| Astellas Pharma US Inc | 1 | $112 |
| Seagen Inc. | 1 | $108 |
| Lilly USA, LLC | 1 | $99 |
| Novo Nordisk | 1 | $97 |
| Gilead | 1 | $94 |
| Edwards Lifesciences | 1 | $90 |
| Inspire Medical Systems, Inc. | 1 | $88 |
| Teva Pharmaceuticals USA, Inc. | 1 | $88 |
| Scynexis, Inc. | 1 | $86 |
| SK Life Science, Inc. | 1 | $85 |
| EMD Serono, Inc. | 1 | $78 |
| Jazz Pharmaceuticals Inc. | 1 | $78 |
| Syndax Pharmaceuticals, Inc. | 1 | $77 |
| Exelixis Inc. | 1 | $73 |
| Coloplast | 1 | $70 |
| Agios Pharmaceuticals, Inc. | 1 | $68 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $67 |
| Baxter Healthcare | 1 | $30 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,378 in reported general payments places this provider in the 90th percentile of 563 primary care providers in Texas.
Other primary care in Galveston
- Mary GibbensHouston$42K
- Phillip GulleySan Antonio$23K
- Herbert BautistaDallas$14K
- Brandi JoynerLongview$12K
- Steven ParisAustin$10K
- Hope OdomCollege Station$10K
- Arlena GraysTomball$9K
- Charlotte BallardSan Antonio$9K
- Hannah LancasterMcKinney$9K
- Jacqueline MilesGrand Prairie$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.